Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management

Satish Chandrashekaran, Patricio Escalante, Cassie C. Kennedy

Research output: Contribution to journalReview articlepeer-review

7 Scopus citations


Mycobacterium abscessus complex (MAbsC) disease in lung transplant recipients is increasingly being recognized as an important cause of graft function decline and suboptimal outcomes. Lung transplant recipients appear to be at the highest risk of MAbsC among solid organ transplant recipients, as they have more intense immunosuppression, and the organisms preferentially inhabit the lungs. MAbsC is the most resistant species of rapidly growing mycobacteria and difficult to treat, causing considerable mortality and morbidity in immunocompetent and immunosuppressed patients. Herein we describe the risk factors, epidemiology, clinical features, diagnostics, and treatment strategies of MAbsC in lung transplant candidates and recipients.

Original languageEnglish (US)
Pages (from-to)10-18
Number of pages9
JournalJournal of Clinical Tuberculosis and Other Mycobacterial Diseases
StatePublished - Dec 2017


  • Lung infection
  • Lung transplant
  • Mycobacterial abscessus complex

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Microbiology (medical)
  • Infectious Diseases


Dive into the research topics of 'Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management'. Together they form a unique fingerprint.

Cite this